NO164092C - Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksamsyrebaserte kollagenaseinhibitorer. - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksamsyrebaserte kollagenaseinhibitorer.Info
- Publication number
- NO164092C NO164092C NO863581A NO863581A NO164092C NO 164092 C NO164092 C NO 164092C NO 863581 A NO863581 A NO 863581A NO 863581 A NO863581 A NO 863581A NO 164092 C NO164092 C NO 164092C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- therapeutic active
- collagenase inhibitors
- analogy procedure
- hydroxic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/774,491 US4599361A (en) | 1985-09-10 | 1985-09-10 | Hydroxamic acid based collagenase inhibitors |
US06/880,130 US4743587A (en) | 1985-09-10 | 1986-07-07 | Hydroxamic acid based collagenase inhibitors |
Publications (4)
Publication Number | Publication Date |
---|---|
NO863581D0 NO863581D0 (no) | 1986-09-08 |
NO863581L NO863581L (no) | 1987-03-11 |
NO164092B NO164092B (no) | 1990-05-21 |
NO164092C true NO164092C (no) | 1990-08-29 |
Family
ID=27118893
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO863581A NO164092C (no) | 1985-09-10 | 1986-09-08 | Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksamsyrebaserte kollagenaseinhibitorer. |
Country Status (14)
Country | Link |
---|---|
US (1) | US4743587A (no) |
EP (1) | EP0214639B1 (no) |
JP (1) | JPH0764800B2 (no) |
CA (1) | CA1329397C (no) |
DE (1) | DE3671891D1 (no) |
DK (1) | DK169029B1 (no) |
FI (1) | FI84472C (no) |
GR (1) | GR862286B (no) |
IE (1) | IE58770B1 (no) |
IL (1) | IL79971A (no) |
NO (1) | NO164092C (no) |
NZ (1) | NZ217491A (no) |
PH (1) | PH24182A (no) |
PT (1) | PT83328B (no) |
Families Citing this family (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0225292A3 (en) * | 1985-12-06 | 1988-11-30 | Ciba-Geigy Ag | Certain n-substituted butyramide derivatives |
US5166212A (en) * | 1985-12-06 | 1992-11-24 | Ciba-Geigy Corporation | Certain n-substituted butyramide derivatives |
US4939299A (en) * | 1986-12-04 | 1990-07-03 | Monsanto Company | Succinyl dihydroxamic acids |
FR2609289B1 (fr) * | 1987-01-06 | 1991-03-29 | Bellon Labor Sa Roger | Nouveaux composes a activite d'inhibiteurs de collagenase, procede pour les preparer et compositions pharmaceutiques contenant ces composes |
US5686422A (en) * | 1987-03-17 | 1997-11-11 | Research Corporation Technologies, Inc. | Synthetic inhibitors of mammalian collagenase |
JP2573006B2 (ja) * | 1987-12-17 | 1997-01-16 | 富士薬品工業株式会社 | 新規なヒドロキサム酸誘導体 |
GB8827305D0 (en) * | 1988-11-23 | 1988-12-29 | British Bio Technology | Compounds |
GB8827308D0 (en) * | 1988-11-23 | 1988-12-29 | British Bio Technology | Compounds |
GB8919251D0 (en) * | 1989-08-24 | 1989-10-04 | British Bio Technology | Compounds |
ES2093699T3 (es) * | 1990-01-25 | 1997-01-01 | Childrens Hosp Medical Center | Metodo y composiciones para inhibir la angiogenesis. |
US5268384A (en) * | 1990-11-21 | 1993-12-07 | Galardy Richard E | Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors |
US5189178A (en) * | 1990-11-21 | 1993-02-23 | Galardy Richard E | Matrix metalloprotease inhibitors |
US5892112A (en) * | 1990-11-21 | 1999-04-06 | Glycomed Incorporated | Process for preparing synthetic matrix metalloprotease inhibitors |
US5239078A (en) * | 1990-11-21 | 1993-08-24 | Glycomed Incorporated | Matrix metalloprotease inhibitors |
US5183900A (en) * | 1990-11-21 | 1993-02-02 | Galardy Richard E | Matrix metalloprotease inhibitors |
US5114953A (en) * | 1990-11-21 | 1992-05-19 | University Of Florida | Treatment for tissue ulceration |
US5889058A (en) * | 1990-12-03 | 1999-03-30 | Celltech Limited | Peptidyl derivatives |
KR927003520A (ko) * | 1990-12-03 | 1992-12-18 | 죤 에드워드 베리만 | 펩티딜(peptidyl) 유도체 |
CA2058797A1 (en) * | 1991-02-01 | 1992-08-02 | Michael John Broadhurst | Amino acid derivatives |
GB9102635D0 (en) * | 1991-02-07 | 1991-03-27 | British Bio Technology | Compounds |
AU2228292A (en) * | 1991-06-14 | 1993-01-12 | Research Corporation Technologies, Inc. | Peptide derivatives of collagenase inhibitor |
US5530161A (en) * | 1991-07-08 | 1996-06-25 | British Bio-Technology Limited | Hydroxamic acid based collagenase inhibitors |
JPH05125029A (ja) * | 1991-11-06 | 1993-05-21 | Yamanouchi Pharmaceut Co Ltd | 新規なアミド化合物又はその塩 |
GB9211706D0 (en) * | 1992-06-03 | 1992-07-15 | Celltech Ltd | Peptidyl derivatives |
GB9211707D0 (en) * | 1992-06-03 | 1992-07-15 | Celltech Ltd | Peptidyl derivatives |
US5318964A (en) * | 1992-06-11 | 1994-06-07 | Hoffmann-La Roche Inc. | Hydroxamic derivatives and pharmaceutical compositions |
AU666727B2 (en) * | 1992-06-25 | 1996-02-22 | F. Hoffmann-La Roche Ag | Hydroxamic acid derivatives |
GB9220845D0 (en) * | 1992-10-03 | 1992-11-18 | British Bio Technology | Vasoactive peptide inhibition |
US5455258A (en) * | 1993-01-06 | 1995-10-03 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamic acids |
US5506242A (en) * | 1993-01-06 | 1996-04-09 | Ciba-Geigy Corporation | Arylsufonamido-substituted hydroxamic acids |
US5646167A (en) * | 1993-01-06 | 1997-07-08 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamix acids |
US5552419A (en) * | 1993-01-06 | 1996-09-03 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamic acids |
US5403824A (en) * | 1993-03-19 | 1995-04-04 | The Procter & Gamble Company | Methods for the treatment of osteoporosis |
WO1995004715A1 (fr) * | 1993-08-09 | 1995-02-16 | Kanebo, Ltd. | Derive d'acylphenylglycine et agent preventif et curatif, concernant des maladies causees par une activite collagenase accrue, contenant un tel compose comme ingredient actif |
GB9501737D0 (en) * | 1994-04-25 | 1995-03-22 | Hoffmann La Roche | Hydroxamic acid derivatives |
WO1995032944A1 (en) * | 1994-05-28 | 1995-12-07 | British Biotech Pharmaceuticals Limited | Succinyl hydroxamic acid, n-formyl-n-hydroxy amino carboxylic acid and succinic acid amide derivatives as metalloprotease inhibitors |
GB9411088D0 (en) * | 1994-06-03 | 1994-07-27 | Hoffmann La Roche | Hydroxylamine derivatives |
US5831004A (en) | 1994-10-27 | 1998-11-03 | Affymax Technologies N.V. | Inhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their use |
US5840698A (en) * | 1994-10-27 | 1998-11-24 | Affymax Technologies N.V. | Inhibitors of collagenase-1 and stormelysin-I metalloproteases, pharmaceutical compositions comprising same and methods of their use |
US5639746A (en) * | 1994-12-29 | 1997-06-17 | The Procter & Gamble Company | Hydroxamic acid-containing inhibitors of matrix metalloproteases |
US5672598A (en) * | 1995-03-21 | 1997-09-30 | The Procter & Gamble Company | Lactam-containing hydroxamic acids |
GB9601041D0 (en) * | 1996-01-17 | 1996-03-20 | Smithkline Beecham Plc | Novel compounds |
EP0925278B1 (en) * | 1996-09-10 | 2002-07-17 | British Biotech Pharmaceuticals Limited | Cytostatic hydroxamic acid derivatives |
EP0911319A1 (en) * | 1997-09-01 | 1999-04-28 | Roche Diagnostics GmbH | Malonic acid based matrix metalloproteinase inhibitors |
GB9804504D0 (en) * | 1998-03-03 | 1998-04-29 | Leo Pharm Prod Ltd | Matrix metalloproteinase inhibitors |
US6329418B1 (en) | 1998-04-14 | 2001-12-11 | The Procter & Gamble Company | Substituted pyrrolidine hydroxamate metalloprotease inhibitors |
US6696456B1 (en) | 1999-10-14 | 2004-02-24 | The Procter & Gamble Company | Beta disubstituted metalloprotease inhibitors |
US6797820B2 (en) | 1999-12-17 | 2004-09-28 | Vicuron Pharmaceuticals Inc. | Succinate compounds, compositions and methods of use and preparation |
BR0109354A (pt) * | 2000-03-21 | 2003-04-15 | Procter & Gamble | Inibidores de metaloproteases os quais contêm cadeias laterais carbocìclicas |
BR0109328A (pt) | 2000-03-21 | 2003-06-10 | Procter & Gamble | Inibidores de metaloprotease n-substituìdos, contendo cadeia lateral heterocìclica |
AU2001245862A1 (en) * | 2000-03-21 | 2001-10-03 | The Procter & Gamble Company | Difluorobutyric acid metalloprotease inhibitors |
US20030229113A1 (en) * | 2000-03-24 | 2003-12-11 | Koji Hashimoto | Keratinocyte growth inhibitors and hydroxamic acid derivatives |
EP2330132B1 (en) | 2003-04-04 | 2013-08-14 | Yeda Research and Development Co. Ltd. | Antibodies against MMP2 or MMP9 and pharmaceutical compositions containing same useful for inhibiting activity of said metalloproteins |
US20060112494A1 (en) * | 2004-12-01 | 2006-06-01 | David Oppong | Method of protecting an animal skin product from metalloproteinase activity |
GB0722484D0 (en) * | 2007-11-15 | 2007-12-27 | Ucl Business Plc | Solid compositions |
GB0818907D0 (en) * | 2008-10-15 | 2008-11-19 | Isis Innovation | Histone lysine demethylase inhibitors |
ES2602826T3 (es) | 2009-05-28 | 2017-02-22 | Novartis Ag | Derivados aminobutíricos sustituidos como inhibidores de neprilisina |
MA33364B1 (fr) | 2009-05-28 | 2012-06-01 | Novartis Ag | Dérivés aminobutyriques substitués en tant qu'inhibiteurs de néprilysine |
US8697078B2 (en) | 2010-01-27 | 2014-04-15 | Yeda Research And Development Co. Ltd. | Antibodies that inhibit metalloproteins |
US10066024B2 (en) | 2010-10-28 | 2018-09-04 | Yeda Research And Development Co. Ltd. | Methods of generating antibodies to metalloenzymes |
AP2015008621A0 (en) | 2013-02-14 | 2015-07-31 | Novartis Ag | Substituted bisphenyl butanoic nep 'neutral endopeptidase' inhibitors |
WO2014126972A1 (en) | 2013-02-14 | 2014-08-21 | Novartis Ag | Substituted bisphenyl butanoic acid derivatives as nep inhibitors with improved in vivo efficacy |
IL264768A (en) | 2019-02-10 | 2020-08-31 | Sagi Irit | ANTI-MATRIX METALLOPROTEINASE 7 (MMP-7) inhibitory antibody and its use |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH438351A (de) * | 1959-09-25 | 1967-06-30 | Ciba Geigy | Verfahren zur Herstellung neuer Wuchsstoffe |
US3471476A (en) * | 1964-05-18 | 1969-10-07 | Tino Gaeumann | Trihydroxamic acids |
US4077998A (en) * | 1975-10-28 | 1978-03-07 | Morton-Norwich Products, Inc. | Phthaloyl amino acid hydroxamic acids |
US4105789A (en) * | 1976-05-10 | 1978-08-08 | E. R. Squibb & Sons, Inc. | Carboxyalkylacylamino acids |
US4028401A (en) * | 1976-07-01 | 1977-06-07 | Morton-Norwich Products, Inc. | (Substituted)ureidoacetohydroxamic acids |
NZ201010A (en) * | 1981-06-19 | 1986-02-21 | Ciba Geigy Ag | The treatment of inflammation diseases using desferrioxamine |
FR2518088B1 (fr) * | 1981-12-16 | 1987-11-27 | Roques Bernard | Nouveaux derives d'aminoacides, et leur application therapeutique |
US4419365A (en) * | 1981-12-21 | 1983-12-06 | Ciba-Geigy Corporation | Method of treating Alzheimer's disease |
-
1986
- 1986-07-07 US US06/880,130 patent/US4743587A/en not_active Expired - Lifetime
- 1986-09-08 DK DK427686A patent/DK169029B1/da not_active IP Right Cessation
- 1986-09-08 FI FI863607A patent/FI84472C/fi not_active IP Right Cessation
- 1986-09-08 EP EP86112386A patent/EP0214639B1/en not_active Expired - Lifetime
- 1986-09-08 IL IL79971A patent/IL79971A/xx not_active IP Right Cessation
- 1986-09-08 NZ NZ217491A patent/NZ217491A/xx unknown
- 1986-09-08 CA CA000517713A patent/CA1329397C/en not_active Expired - Fee Related
- 1986-09-08 PH PH34231A patent/PH24182A/en unknown
- 1986-09-08 GR GR862286A patent/GR862286B/el unknown
- 1986-09-08 PT PT83328A patent/PT83328B/pt unknown
- 1986-09-08 DE DE8686112386T patent/DE3671891D1/de not_active Expired - Lifetime
- 1986-09-08 NO NO863581A patent/NO164092C/no not_active IP Right Cessation
- 1986-09-09 IE IE240486A patent/IE58770B1/en not_active IP Right Cessation
- 1986-09-09 JP JP61212539A patent/JPH0764800B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
FI84472B (fi) | 1991-08-30 |
IL79971A0 (en) | 1986-12-31 |
FI84472C (fi) | 1991-12-10 |
PT83328B (pt) | 1988-07-29 |
IE58770B1 (en) | 1993-11-03 |
AU6240886A (en) | 1987-03-12 |
FI863607A (fi) | 1987-03-11 |
NO164092B (no) | 1990-05-21 |
NO863581L (no) | 1987-03-11 |
IL79971A (en) | 1990-11-05 |
DK427686D0 (da) | 1986-09-08 |
JPH0764800B2 (ja) | 1995-07-12 |
US4743587A (en) | 1988-05-10 |
GR862286B (en) | 1987-01-12 |
DE3671891D1 (de) | 1990-07-19 |
IE862404L (en) | 1987-03-10 |
CA1329397C (en) | 1994-05-10 |
AU588362B2 (en) | 1989-09-14 |
PT83328A (pt) | 1986-10-01 |
FI863607A0 (fi) | 1986-09-08 |
EP0214639A3 (en) | 1988-02-17 |
DK427686A (da) | 1987-03-11 |
JPS62103052A (ja) | 1987-05-13 |
EP0214639A2 (en) | 1987-03-18 |
NO863581D0 (no) | 1986-09-08 |
NZ217491A (en) | 1989-10-27 |
DK169029B1 (da) | 1994-08-01 |
PH24182A (en) | 1990-03-22 |
EP0214639B1 (en) | 1990-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO164092C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksamsyrebaserte kollagenaseinhibitorer. | |
NO169543C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive peptidaseinhibitorer | |
NO163406C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater. | |
NO862477D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater. | |
NO864126D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater. | |
NO170023C (no) | Analogifremgangsmaate for fremstilling av nye terapeutisk aktive alfa-glucosidaseinhibitorer | |
NO851949L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotetralinderivater. | |
NO167384C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n-aralkylpiperidinmethanolderivater. | |
NO864879L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser. | |
NO164097C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-hetero-aryl-tiazol-derivater. | |
NO864674D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser. | |
NO167026C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater | |
NO169438C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrazolforbindelser | |
NO862373D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner. | |
NO164897C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater. | |
NO164295C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive fluorerte benzyltriazolforbindelser. | |
NO161559C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive triazolderivater. | |
NO862372D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater. | |
NO165069C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklopentyletere. | |
NO170582C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aryl-piperazinyl-alkylenfenyl-heterocykliske forbindelser | |
NO160511C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklo-butanderivater. | |
NO164899C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser. | |
NO169169C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive substituerte benzimidazoler | |
NO168478C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylthioacetamido-oxacefalosporinderivater. | |
NO164895C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |